Newsroom | 41735 results
Sorted by: Latest
-
United States Otorhinolaryngology KOLs Fair-Market Value Compensation Rates Report 2025: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "United States Fair-Market Value Compensation Rates for Otorhinolaryngology KOLs" report has been added to ResearchAndMarkets.com's offering. This report presents fair-market value (FMV) hourly and half-day compensation rates for U.S. KOLs - Otorhinolaryngology, by percentiles, with averages, for four (4) levels of Thought Leader influences (rare, international, national and local). Thought Leader Compensation US Otorhinolaryngology These defensible market-based rat...
-
Dial A Vet Crowned Innovation Champion at Finder Awards 2025, Also a Finalist for Tech Innovation
BRISBANE, Australia--(BUSINESS WIRE)--Dial A Vet, the global veterinary telehealth platform transforming access to pet care, has been named Innovation Champion at the 2025 Finder Innovation Awards, while also being recognised as a finalist in the Tech Innovation category. The Finder Innovation Awards celebrate Australian businesses leading the way in creativity and technology-driven impact. Dial A Vet stood out for its mission to make professional veterinary advice accessible within minutes - o...
-
Fulgent to Participate in Upcoming Conferences
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that members of its management team are scheduled to present at the following upcoming investor conferences: UBS Global Healthcare Conference on Monday, November 10th at 5:00 PM Eastern Time Piper Sandler 37th Annual Healthcare Conference on Tuesday, December...
-
Graham Holdings Company Announces Virtual Investor Day
ARLINGTON, Va.--(BUSINESS WIRE)--Graham Holdings Company (NYSE: GHC) announced today that it will hold a virtual Investor Day on Tuesday, December 9, 2025. The live webcast will be held from 1:00 p.m. to 2:30 p.m. Eastern Time (ET) and will include audio and presentation slides. There will be a discussion of the Company’s operations and financials, as well as a presentation from the Graham Holdings management team. Registration is required. Please visit the Company’s website at www.ghco.com to...
-
Brain Balance Expands to Wayne, Pennsylvania, Led by Integrative Pediatrician Dr. Teresa Fuller
NAPERVILLE, Ill.--(BUSINESS WIRE)--Brain Balance, a leading brain health and development program designed to help children and adults improve focus, behavior, and emotional well-being through a holistic, multimodal approach, is proud to announce the opening of a new center in Wayne, Pennsylvania. The center is owned and operated by Dr. Teresa Fuller, an author, speaker, and integrative holistic pediatrician with more than two decades of experience helping families achieve lasting wellness. Dr....
-
Telemedicina e inteligencia artificial: Itaca lanza notas clínicas automáticas desde videollamadas
Ciudad de México--(BUSINESS WIRE)--La telemedicina se consolidó como una práctica habitual desde la pandemia de COVID-19 y hoy forma parte esencial de la atención médica en múltiples especialidades. Itaca, una plataforma de IA médica, responde a la creciente necesidad de documentar teleconsultas con precisión, permitiendo generar notas clínicas automáticas desde videollamadas. Usada por más de 20,000 profesionales de la salud en América Latina, la herramienta busca facilitar la documentación mé...
-
Telemedicine and Artificial Intelligence: Itaca Introduces Automatic Clinical Notes from Video Calls
MEXICO CITY--(BUSINESS WIRE)--Itaca adds AI-powered clinical notes for telemedicine, generating clinical notes from Google Meet, Zoom, or Microsoft Teams video calls...
-
Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of subcutaneous mezagitamab (TAK-079), an anti-CD38 monoclonal antibody with disease-modifying potential, in primary immunoglobulin A (IgA) nephropathy. Data from the study showed that kidney function (eGFR) remained stable in patients with IgA nephropathy through Week 96 – up to 18 months after the last mezagitamab dose.1 The result...
-
CMS Partners with Humata Health on Initiative to Make Clinical Approvals Faster, Fairer and More Efficient
WINTER PARK, Fla.--(BUSINESS WIRE)--Humata Health, the leader in AI-powered prior authorization technology, has been selected by the Centers for Medicare & Medicaid (CMS) as a key partner for its WISeR model, an initiative focused on safeguarding patients and protecting Medicare funds. Humata will use its proprietary technology to help build a more modern, efficient and fair clinical approval process for CMS, the single largest payer for healthcare in the U.S. The WISeR model — which launch...
-
Canada Endocrinology KOLs Fair-Market Value Compensation Rates Report 2025: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Canada Fair-Market Value Compensation Rates for Endocrinology KOLs" report has been added to ResearchAndMarkets.com's offering. This report presents fair-market value compensation rates for Canadian KOLs in endocrinology, by percentiles, with averages, for four (4) levels of Thought Leader influences (rare, international, national, and local). These defensible market-based rate data are built directly from industry compensation paid to Healthcare Practitioners (HCP...